Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Feb;47(2):269–275. doi: 10.1038/bjc.1983.35

Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

G Secreto, C Recchione, A Cavalleri, M Miraglia, V Dati
PMCID: PMC2011282  PMID: 6824571

Abstract

Serum testosterone, 17 beta-oestradiol, luteinising hormone (LH) and prolactin were measured in 28 postmenopausal breast cancer patients after mastectomy and in 30 postmenopausal normal controls. In the patient group, mean levels of oestradiol, LH and prolactin did not differ significantly from those of the control group. Mean testosterone levels were higher in breast cancer patients than in normal controls, either considering the overall groups (P less than 0.001) or dividing them into subgroups according to years since menopause. Breast cancer patients were divided into 2 subgroups according to time since mastectomy: 19 patients had been examined within a year of mastectomy and 9 patients some years after mastectomy. Testosterone, but not oestradiol, LH or prolactin values in each subgroup were still significantly higher (P less than 0.001 and P less than 0.02, respectively) than in normal controls. Years since menopause were significantly correlated with testosterone (r = 0.533, P less than 0.01) but not with the other hormones in the cancer group. These results confirm our previous findings of increased urinary testosterone values in postmenopausal breast cancer patients and support the hypothesis that androgens may play a role in the development of breast cancer.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Johansson E. D., Vegelius J., Victor A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci. 1979;84(3):259–274. doi: 10.3109/03009737909179163. [DOI] [PubMed] [Google Scholar]
  2. Bird C. E., Cook S., Owen S., Sterns E. E., Clark A. F. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer. Oncology. 1981;38(6):365–368. doi: 10.1159/000225589. [DOI] [PubMed] [Google Scholar]
  3. Borkowski A., L'hermite M., Dor P., Longeval E., Rozencweig M., Muquardt C., Van Cauter E. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment. J Endocrinol. 1977 May;73(2):235–246. doi: 10.1677/joe.0.0730235. [DOI] [PubMed] [Google Scholar]
  4. Collins W. P., Mansfield M. D., Alladina N. S., Sommerville I. F. Radioimmunoassay of plasma testosterone. J Steroid Biochem. 1972 Apr;3(3):333–348. doi: 10.1016/0022-4731(72)90080-5. [DOI] [PubMed] [Google Scholar]
  5. Desbuquois B., Aurbach G. D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971 Nov;33(5):732–738. doi: 10.1210/jcem-33-5-732. [DOI] [PubMed] [Google Scholar]
  6. England P. C., Skinner L. G., Cottrell K. M., Sellwood R. A. Sex hormones in breast disease. Br J Surg. 1975 Oct;62(10):806–809. doi: 10.1002/bjs.1800621014. [DOI] [PubMed] [Google Scholar]
  7. Franks S., Ralphs D. N., Seagroatt V., Jacobs H. S. Prolactin concentrations in patients with breast cancer. Br Med J. 1974 Nov 9;4(5940):320–321. doi: 10.1136/bmj.4.5940.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grattarola R. Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone excretion. J Natl Cancer Inst. 1976 Jan;56(1):11–16. doi: 10.1093/jnci/56.1.11. [DOI] [PubMed] [Google Scholar]
  10. Grattarola R., Secreto G., Recchione C. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity. Am J Obstet Gynecol. 1975 Jan 15;121(2):169–172. [PubMed] [Google Scholar]
  11. Grattarola R., Secreto G., Recchione C., Castellini W. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol. 1974 Jan 15;118(2):173–178. [PubMed] [Google Scholar]
  12. Gratterola R. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res. 1978 Sep;38(9):3051–3054. [PubMed] [Google Scholar]
  13. Grodin J. M., Siiteri P. K., MacDonald P. C. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973 Feb;36(2):207–214. doi: 10.1210/jcem-36-2-207. [DOI] [PubMed] [Google Scholar]
  14. Horn H., Gordan G. S. Plasma testosterone in advanced breast cancer. Oncology. 1974;30(2):147–151. doi: 10.1159/000224950. [DOI] [PubMed] [Google Scholar]
  15. Ismail A. A., Niswender G. D., Midgley A. R., Jr Radioimmunoassay of testosterone without chromatography. J Clin Endocrinol Metab. 1972 Jan;34(1):177–184. doi: 10.1210/jcem-34-1-177. [DOI] [PubMed] [Google Scholar]
  16. Jones M. K., Ramsay I. D., Booth M., Collins W. P. Hormone concentrations in postmenopausal patients with breast cancer. Clin Oncol. 1977 Jun;3(2):177–181. [PubMed] [Google Scholar]
  17. Judd H. L., Davidson B. J., Frumar A. M., Shamonki I. M., Lagasse L. D., Ballon S. C. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol. 1980 Apr 1;136(7):859–871. doi: 10.1016/0002-9378(80)91043-1. [DOI] [PubMed] [Google Scholar]
  18. Judd H. L., Judd G. E., Lucas W. E., Yen S. S. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974 Dec;39(6):1020–1024. doi: 10.1210/jcem-39-6-1020. [DOI] [PubMed] [Google Scholar]
  19. Judd H. L., Lucas W. E., Yen S. S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974 Mar 15;118(6):793–798. doi: 10.1016/0002-9378(74)90490-6. [DOI] [PubMed] [Google Scholar]
  20. Kwa H. G., De Jong-Bakker M., Engelsman E., Cleton F. J. Plasma-prolactin in human breast cancer. Lancet. 1974 Mar 16;1(7855):433–435. doi: 10.1016/s0140-6736(74)92385-x. [DOI] [PubMed] [Google Scholar]
  21. Malarkey W. B., Schroeder L. L., Stevens V. C., James A. G., Lanese R. R. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res. 1977 Dec;37(12):4655–4659. [PubMed] [Google Scholar]
  22. McFadyen I. J., Forrest A. P., Prescott R. J., Golder M. P., Groom G. V., Fahmy D. R., Griffiths K. Circulating hormone concentrations in women with breast cancer. Lancet. 1976 May 22;1(7969):1100–1102. doi: 10.1016/s0140-6736(76)90064-7. [DOI] [PubMed] [Google Scholar]
  23. Midgley A. R., Jr Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology. 1966 Jul;79(1):10–18. doi: 10.1210/endo-79-1-10. [DOI] [PubMed] [Google Scholar]
  24. Mittra I., Hayward J. L., McNeilly A. S. Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet. 1974 May 11;1(7863):889–891. doi: 10.1016/s0140-6736(74)90345-6. [DOI] [PubMed] [Google Scholar]
  25. Nagasawa H. Prolactin and human breast cancer: a review. Eur J Cancer. 1979 Mar;15(3):267–279. doi: 10.1016/0014-2964(79)90037-9. [DOI] [PubMed] [Google Scholar]
  26. Nimrod A., Ryan K. J. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab. 1975 Mar;40(3):367–372. doi: 10.1210/jcem-40-3-367. [DOI] [PubMed] [Google Scholar]
  27. Nisker J. A., Siiteri P. K. Estrogens and breast cancer. Clin Obstet Gynecol. 1981 Mar;24(1):301–322. doi: 10.1097/00003081-198103000-00025. [DOI] [PubMed] [Google Scholar]
  28. Rice B. F., Savard K. Steroid hormone formation in the human ovary. IV. Ovarian stromal compartment; formation of radioactive steroids from acetate-1-14C and action of gonadotropins. J Clin Endocrinol Metab. 1966 Jun;26(6):593–609. doi: 10.1210/jcem-26-6-593. [DOI] [PubMed] [Google Scholar]
  29. SMITH G. V., SMITH O. W. Carcinoma of the breast; results, evaluation of X-radiation, and relation of age and surgical castration to length of survival. Surg Gynecol Obstet. 1953 Oct;97(4):508–516. [PubMed] [Google Scholar]
  30. SOMMERS S. C. Endocrine abnormalities in women with brest cancer. Lab Invest. 1955 May-Jun;4(3):160–174. [PubMed] [Google Scholar]
  31. SOMMERS S. C., TELOH H. A. Ovarian stromal hyperplasia in breast cancer. AMA Arch Pathol. 1952 Feb;53(2):160–166. [PubMed] [Google Scholar]
  32. Schenker J. G., Weinstein D., Okon E. Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer. 1979 Nov;44(5):1809–1812. doi: 10.1002/1097-0142(197911)44:5<1809::aid-cncr2820440540>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  33. Sheth N. A., Ranadive K. J., Suraiya J. N., Sheth A. R. Circulating levels of prolactin in human breast cancer. Br J Cancer. 1975 Aug;32(2):160–167. doi: 10.1038/bjc.1975.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973 Mar;36(3):509–516. doi: 10.1210/jcem-36-3-509. [DOI] [PubMed] [Google Scholar]
  35. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976 Feb;42(2):247–253. doi: 10.1210/jcem-42-2-247. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES